The National Organization for Rare Disorders (NORD) recently announced the three keynote speakers who are scheduled to present at the 2016 Rare Diseases and Orphan Products Breakthrough Summit Oct. 17-18 in Arlington, Virginia.

The National Osteoporosis Foundation (NOF) Online Community, hosted by Inspire, recently announced that it now has over 30,000 members involved in the patient and caregiver peer-to-peer support group.

Leaders from the American Heart Association (AHA), AstraZeneca and Verily Life Sciences LLC recently announced the winner of the One Brave Idea research award: Dr. Calum MacRae, chief of cardiovascular medicine at Boston’s Brigham and Women’s Hospital.

The National Institute of Environmental Health Sciences (NIEHS), a part of the National Institutes of Health (NIH), recently highlighted 12 individuals who are leaders in the field of environmental health research.

The U.S. Food and Drug Administration (FDA) recently approved the world’s first hybrid insulin delivery system, a decision that the American Diabetes Association (ADA) supports.

Officials with the U.S. Food and Drug Administration recently warned consumers that some homeopathic gels and tablets designed for teething could be risky for children and infants.

Amgen recently announced that its research has revealed new data for Imlygic (talimogene laherparepvec) to treat melanoma and metastatic colorectal cancer, stating that the information will be presented at the European Society for Medical Oncology 2016 Congress.

Leaders with the U.S. Food and Drug Administration (FDA) recently expanded its approval of Ilaris to include three new indications of rare diseases for adult as well as pediatric patients.

Boehringer Ingelheim and ViraTherapeutics recently formed a long-term partnership to create a next-generation oncolytic virus therapy platform and evaluate a top candidate Vesicular Stomatitis Virus (VSV) glycoprotein (GP).

Mental Illness Awareness Week runs Oct. 2-8, highlighting mental health challenges in addition to honoring publications about bipolar disorder, anxiety and depression.

Sue Dubman, a health care and informatics researcher who has Parkinson’s disease, recently wrote an article in the 'Journal of Parkinson’s Disease' to explain that she wants to share her information to further scientific research.

The National Organization for Rare Disorders (NORD) recently joined over 300 organizations on Capitol Hill in the Rally for Medical Research Hill Day on Sept. 22, urging leaders to raise funds for the National Institutes of Health (NIH).

The Leukemia and Lymphoma Society (LLS) and WealthEngine (WE), the top supplier of predictive analytics, marketing and audience development services, recently partnered to raise funds for blood cancer research.

Global Genes recently launched its fifth annual RARE Tribute to Champions of Hope and Patient Advocacy Summit, raising more than $1.4 million meant to fund rare disease awareness, education and grant programs.

Chembio Diagnostics Inc., a leader in point-of-care (POC) diagnostic tests for infectious diseases, recently received a contract from the Centers for Disease Control and Prevention (CDC) for surveillance diagnostic assays for Zika, dengue and chikungunya.

The U.S. Food and Drug Administration (FDA) recently approved a Biologics License Application (BLA) for a GlaxoSmithKline plc (GSK) sirukumab that is designed to treat rheumatoid arthritis.

The U.S. Senate has unanimously voted to lengthen the Rare Pediatric Disease Priority Review Voucher (PRV) Program, speeding up treatments for 15 million children living with rare diseases.

Chairmen and ranking members of the Senate Health Committee and House Energy and Commerce Committee recently stated that they are making progress in reaching a bipartisan deal for the 21st Century Cures legislation.

More than 700 Tina’s Wish supporters recently gathered at the Museum of Natural History to raise a total of $1.4 million that is dedicated to early detection ovarian cancer research.

The National Organization for Rare Disorders (NORD), an independent nonprofit organization that represents 30 million U.S. residents with rare diseases, recently received federal funds to help stop the Zika virus.